Anes/CCM – Immunosuppression
-
![]()
State-of-the-Art Lecture: Individualized Approach to Immunosuppression and Transplantation for Hepatocellular Carcinoma
For ILTS members only, please join now or renew your membership.
- Hepatocellular carcinoma and 1 more ∙
- Geoff McCaughan and 1 others ∙
- State-Of-The-Art Lecture ∙ Webinar ∙ April 19, 2021
-
![]()
ILTS Insights: Markers of rejection and of tolerance in liver transplantation current tools and futures candidate
For ILTS members only, please join now or renew your membership.
- Immunosuppression and 2 more ∙
- Alberto Sanchez Fueyo and 4 others ∙
- ILTS Insights ∙ Webinar ∙ December 7, 2020
-
Vanguard Report: Marginal Candidate, Viral Hepatitis, Immunosuppression
For ILTS members only, please join now or renew your membership.
- Acute liver failure and 13 more ∙
- de Martin E ∙
- 2018 ELITA & LICAGE Lisbon ∙ Literature ∙ June 12, 2018
-
Immunosuppression Protocols: Diagnosis, Impact and Management of Antibody-Mediated Rejection in Liver Transplantation
For ILTS members only, please join now or renew your membership.
- Immunosuppression ∙
- Julie Heimbach ∙
- 2017 Immunosuppression in Liver Transplantation - Park City ∙ Lecture ∙ March 14, 2017
-
Renal Protective Effects of Everolimus in Liver Transplant Patients
For ILTS members only, please join now or renew your membership.
- Hepatorenal / electrolytes and 1 more ∙
- Kerstin Herzer ∙
- 2013 LICAGE Essen ∙ Lecture ∙ September 13, 2013
